成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 4382-63-2 Chemical Structure| 4382-63-2
Chemical Structure| 4382-63-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 4382-63-2

,{[proInfo.pro_purity]}

PFK-015 is an effective inhibitor of PFKFB3 with IC50 of 110 nM (recombinant PFKFB3) and inhibits PFKFB3 activity in cancer cells with IC50 of 20 nM.

Synonyms: PFK15

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of PFK-015

CAS No. :4382-63-2
Formula : C17H12N2O
M.W : 260.29
SMILES Code : O=C(C1=CC=NC=C1)C=CC2=NC3=CC=CC=C3C=C2
Synonyms :
PFK15
MDL No. :MFCD28099813
InChI Key :UJJUKZPBUMCSJZ-BQYQJAHWSA-N
Pubchem ID :25142799

Safety of PFK-015

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Autophagy

    PFKFB3, IC50:207 nM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
N1S1 5 mg/mL 4 h PFK15 significantly inhibited N1S1 proliferation, showing a reduced lactate flux and growth. PMC9672450
MIA PaCa-2 cells 10 μM 72 hours To assess the effects of PFK15 on cell proliferation and viability, results showed that PFK15 significantly reduced MIA PaCa-2 cell proliferation and induced cell death PMC7114799
BxPC-3 cells 10 μM 24 hours To assess the effects of PFK15 on apoptosis, results showed that PFK15 significantly increased PARP cleavage in BxPC-3 cells, indicating apoptosis PMC7114799
PANC1 cells 10 μM 96 hours To assess the effects of PFK15 on cell proliferation, results showed that PFK15 significantly reduced PANC1 cell proliferation PMC7114799
HPSCs cells 10 μM 24 hours To assess the effects of PFK15 on apoptosis, results showed that PFK15 had no significant effect on HPSCs PMC7114799

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Fischer rats orthotopic HCC model Intraperitoneal injection 25 mg/kg 3 days post-stimulation PFK15 administration reduced lactate production and tumor growth. PMC9672450

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.84mL

0.77mL

0.38mL

19.21mL

3.84mL

1.92mL

38.42mL

7.68mL

3.84mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories